Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

E64FC26

SKU: orb1709807

Description

E64FC26 is a pan-inhibitor of the protein disulfide isomerase (PDI) family, targeting members including PDIA1, PDIA3, PDIA4, TXNDC5, and PDIA6. It exhibits antitumor activity and is a useful research tool for studying cancers such as multiple myeloma and pancreatic cancer in both in vitro and in vivo models.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number2285446-62-8
MW340.38
Purity98.10% (May vary between batches)
FormulaC19H23F3O2
SMILESC(F)(F)(F)C=1C=2C(\C(=C\CCCCCCCC)\C1)=CC(O)=C(O)C2
TargetApoptosis,Others
Solubility10% DMSO+90% Saline:3.3 mg/mL (9.7 mM);DMSO:80 mg/mL (235.03 mM)

Bioactivity

Target IC50
anti-multiple myeloma:0.59 μM (EC50)
In Vivo
In the NSG mouse model, E64FC26 (2 mg/kg; intraperitoneal injection; three times a week for 7 days) demonstrates anti-multiple myeloma (MM) effects, extending the median survival by 2 weeks. The maximum improvement in median survival is observed with both E64FC26 and Bortezomib, leading to a 20-day extension in median survival.The pharmacokinetics of E64FC26 were measured in CD-1 mice. E64FC26 was administered via intravenous injection (2 mg/kg; gray trace) or oral administration (5 mg/kg; blue trace), and plasma drug concentrations were measured within 24 hours. In CD-1 mice, after a single oral dose of 5 mg/kg, the maximum concentration (Cmax) reached 400 nM with a terminal half-life of 9.5 hours, demonstrating sufficient oral bioavailability of 34%. Vk*MYC transgenic mice were treated with E64FC26 (2 mg/kg, intraperitoneal injection, 3 days/week) for two consecutive weeks. E64FC26 treatment induces an immediate anti-MM response, resulting in an average reduction of 33 ± 7.9% in serum M protein for all mice.
In Vitro
E64FC26 exhibits anti-multiple myeloma (MM) activity with an EC50 of 0.59 μM after 24 hours of treatment in a concentration range of 0.01-100 μM. E64FC26 demonstrates significant cytotoxicity in a panel of genetically diverse multiple myeloma cell lines (KMS11, OPM2, MM.1S BzR, MM.1S, SA-13, U266 BzR, ANBL6, KMS12PE, U266, 8226 DxR, 8226 BzR, KMS12BM, H929, 8226 cells).

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

E64FC26, E-64FC26, protein disulfide isomerase (PDI)

Similar Products

  • (E/Z)-E64FC26 [orb1691036]

    98.23% (May vary between batches)

    2285446-67-3

    340.38

    C19H23F3O2

    5 mg, 1 mg, 2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 210.00
5 mg
$ 440.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry